未登录

B

Birgitte Andersen

Neurology

H指数:34

被引数:3,656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epileptiform discharges in neurodegenerative diseases linked to atrophy but not associated with iron depositions

与萎缩相关但与铁沉积无关的神经退行性疾病中的癫痫样放电

IF5.4

2026-05-270

OAAI

The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASH

IF2.6

2025-10-280

PRE

Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans

IF6.9

2024-08-010

OAAI

Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-07-160

OAAI

Identification and engineering of potent cyclic peptides with selective or promiscuous binding through biochemical profiling and bioinformatic data analysis

RSC CHEMICAL BIOLOGY

IF3.1

2024-01-015

OAAI

Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2023-08-016

OA

Subclinical Epileptiform Activity in Dementia with Lewy Bodies

MOVEMENT DISORDERS

IF7.6

2023-07-118

OAAI

Detection of subclinical epileptiform discharges in Alzheimer's disease using long-term outpatient EEG monitoring

NEUROBIOLOGY OF DISEASE

IF5.6

2023-07-0115

OAAI

Long-Term EEG Monitoring in Patients with Alzheimer's Disease Using Ear-EEG: A Feasibility Study

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2022-12-066

PRE

A pyrexic effect of FGF21 independent of energy expenditure and UCP1

MOLECULAR METABOLISM

IF6.6

2021-11-0114

OAAI

FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2020-12-2265

OAAI

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer's Disease

FRONTIERS IN NEUROSCIENCE

IF3.2

2020-05-276

OAAI

Whole transcriptome analysis and validation of metabolic pathways in subcutaneous adipose tissues during FGF21-induced weight loss in non-human primates

SCIENTIFIC REPORTS

IF3.9

2020-04-299

OAAI

Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-01-3170

OAAI

Oscillatory connectivity as a diagnostic marker of dementia due to Alzheimer's disease

CLINICAL NEUROPHYSIOLOGY

IF3.6

2019-10-0125

OAAI

FGF21 and a β3-Adrenergic Agonist Synergistically Lower Blood Glucose in Obese Mice at Thermoneutrality

IF7.5

2019-06-010

PRE

FGF21 decreases food intake and body weight in obese Gottingen minipigs

DIABETES OBESITY & METABOLISM

IF5.7

2018-11-2019

PREAI

Fasting decreases plasma FGF21 in obese subjects and the expression of FGF21 receptors in adipose tissue in both lean and obese subjects

JOURNAL OF ENDOCRINOLOGY

IF3.9

2018-10-0120

OAAI

Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in db/db mice

BIOCHEMICAL JOURNAL

IF4.3

2018-09-2519

PREAI

EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2018-07-06134

PREAI